264 related articles for article (PubMed ID: 23794606)
21. High-dose biotin restores redox balance, energy and lipid homeostasis, and axonal health in a model of adrenoleukodystrophy.
Fourcade S; Goicoechea L; Parameswaran J; Schlüter A; Launay N; Ruiz M; Seyer A; Colsch B; Calingasan NY; Ferrer I; Beal MF; Sedel F; Pujol A
Brain Pathol; 2020 Sep; 30(5):945-963. PubMed ID: 32511826
[TBL] [Abstract][Full Text] [Related]
22. Adenoassociated virus serotype 9-mediated gene therapy for x-linked adrenoleukodystrophy.
Gong Y; Mu D; Prabhakar S; Moser A; Musolino P; Ren J; Breakefield XO; Maguire CA; Eichler FS
Mol Ther; 2015 May; 23(5):824-834. PubMed ID: 25592337
[TBL] [Abstract][Full Text] [Related]
23. Astrocytes and mitochondria from adrenoleukodystrophy protein (ABCD1)-deficient mice reveal that the adrenoleukodystrophy-associated very long-chain fatty acids target several cellular energy-dependent functions.
Kruska N; Schönfeld P; Pujol A; Reiser G
Biochim Biophys Acta; 2015 May; 1852(5):925-36. PubMed ID: 25583114
[TBL] [Abstract][Full Text] [Related]
24. HDAC inhibitor SAHA normalizes the levels of VLCFAs in human skin fibroblasts from X-ALD patients and downregulates the expression of proinflammatory cytokines in Abcd1/2-silenced mouse astrocytes.
Singh J; Khan M; Singh I
J Lipid Res; 2011 Nov; 52(11):2056-69. PubMed ID: 21891797
[TBL] [Abstract][Full Text] [Related]
25. Pathophysiology of X-linked adrenoleukodystrophy.
Berger J; Forss-Petter S; Eichler FS
Biochimie; 2014 Mar; 98(100):135-42. PubMed ID: 24316281
[TBL] [Abstract][Full Text] [Related]
26. Early oxidative damage underlying neurodegeneration in X-adrenoleukodystrophy.
Fourcade S; López-Erauskin J; Galino J; Duval C; Naudi A; Jove M; Kemp S; Villarroya F; Ferrer I; Pamplona R; Portero-Otin M; Pujol A
Hum Mol Genet; 2008 Jun; 17(12):1762-73. PubMed ID: 18344354
[TBL] [Abstract][Full Text] [Related]
27. Functional overlap between ABCD1 (ALD) and ABCD2 (ALDR) transporters: a therapeutic target for X-adrenoleukodystrophy.
Pujol A; Ferrer I; Camps C; Metzger E; Hindelang C; Callizot N; Ruiz M; Pàmpols T; Giròs M; Mandel JL
Hum Mol Genet; 2004 Dec; 13(23):2997-3006. PubMed ID: 15489218
[TBL] [Abstract][Full Text] [Related]
28. X-linked adrenoleukodystrophy enigma: how does the ALD peroxisomal transporter mutation affect CNS glia?
Aubourg P; Dubois-Dalcq M
Glia; 2000 Jan; 29(2):186-90. PubMed ID: 10625338
[No Abstract] [Full Text] [Related]
29. Cholesterol regulates ABCD2 expression: implications for the therapy of X-linked adrenoleukodystrophy.
Weinhofer I; Forss-Petter S; Zigman M; Berger J
Hum Mol Genet; 2002 Oct; 11(22):2701-8. PubMed ID: 12374760
[TBL] [Abstract][Full Text] [Related]
30. ABCD1 and X-linked adrenoleukodystrophy: A disease with a markedly variable phenotype showing conserved neurobiology in animal models.
Manor J; Chung H; Bhagwat PK; Wangler MF
J Neurosci Res; 2021 Dec; 99(12):3170-3181. PubMed ID: 34716609
[TBL] [Abstract][Full Text] [Related]
31. Drug discovery for X-linked adrenoleukodystrophy: An unbiased screen for compounds that lower very long-chain fatty acids.
Moser AB; Liu Y; Shi X; Schrifl U; Hiebler S; Fatemi A; Braverman NE; Steinberg SJ; Watkins PA
J Cell Biochem; 2021 Oct; 122(10):1337-1349. PubMed ID: 34056752
[TBL] [Abstract][Full Text] [Related]
32. Oxidative stress underlying axonal degeneration in adrenoleukodystrophy: a paradigm for multifactorial neurodegenerative diseases?
Galea E; Launay N; Portero-Otin M; Ruiz M; Pamplona R; Aubourg P; Ferrer I; Pujol A
Biochim Biophys Acta; 2012 Sep; 1822(9):1475-88. PubMed ID: 22353463
[TBL] [Abstract][Full Text] [Related]
33. Autophagy induction halts axonal degeneration in a mouse model of X-adrenoleukodystrophy.
Launay N; Aguado C; Fourcade S; Ruiz M; Grau L; Riera J; Guilera C; Giròs M; Ferrer I; Knecht E; Pujol A
Acta Neuropathol; 2015 Mar; 129(3):399-415. PubMed ID: 25549970
[TBL] [Abstract][Full Text] [Related]
34. Imbalanced mitochondrial dynamics contributes to the pathogenesis of X-linked adrenoleukodystrophy.
Launay N; Lopez-Erauskin J; Bianchi P; Guha S; Parameswaran J; Coppa A; Torreni L; Schlüter A; Fourcade S; Paredes-Fuentes AJ; Artuch R; Casasnovas C; Ruiz M; Pujol A
Brain; 2024 Jun; 147(6):2069-2084. PubMed ID: 38763511
[TBL] [Abstract][Full Text] [Related]
35. Bezafibrate lowers very long-chain fatty acids in X-linked adrenoleukodystrophy fibroblasts by inhibiting fatty acid elongation.
Engelen M; Schackmann MJ; Ofman R; Sanders RJ; Dijkstra IM; Houten SM; Fourcade S; Pujol A; Poll-The BT; Wanders RJ; Kemp S
J Inherit Metab Dis; 2012 Nov; 35(6):1137-45. PubMed ID: 22447153
[TBL] [Abstract][Full Text] [Related]
36. Oxidative stress, mitochondrial and proteostasis malfunction in adrenoleukodystrophy: A paradigm for axonal degeneration.
Fourcade S; Ferrer I; Pujol A
Free Radic Biol Med; 2015 Nov; 88(Pt A):18-29. PubMed ID: 26073123
[TBL] [Abstract][Full Text] [Related]
37. A very long-chain acyl-CoA synthetase-deficient mouse and its relevance to X-linked adrenoleukodystrophy.
Heinzer AK; Watkins PA; Lu JF; Kemp S; Moser AB; Li YY; Mihalik S; Powers JM; Smith KD
Hum Mol Genet; 2003 May; 12(10):1145-54. PubMed ID: 12719378
[TBL] [Abstract][Full Text] [Related]
38. Evidence of oxidative stress in very long chain fatty acid--treated oligodendrocytes and potentialization of ROS production using RNA interference-directed knockdown of ABCD1 and ACOX1 peroxisomal proteins.
Baarine M; Andréoletti P; Athias A; Nury T; Zarrouk A; Ragot K; Vejux A; Riedinger JM; Kattan Z; Bessede G; Trompier D; Savary S; Cherkaoui-Malki M; Lizard G
Neuroscience; 2012 Jun; 213():1-18. PubMed ID: 22521832
[TBL] [Abstract][Full Text] [Related]
39. ABC subfamily D proteins and very long chain fatty acid metabolism as novel targets in adrenoleukodystrophy.
Morita M; Shimozawa N; Kashiwayama Y; Suzuki Y; Imanaka T
Curr Drug Targets; 2011 May; 12(5):694-706. PubMed ID: 21039332
[TBL] [Abstract][Full Text] [Related]
40. X-linked adrenoleukodystrophy in women: a cross-sectional cohort study.
Engelen M; Barbier M; Dijkstra IM; Schür R; de Bie RM; Verhamme C; Dijkgraaf MG; Aubourg PA; Wanders RJ; van Geel BM; de Visser M; Poll-The BT; Kemp S
Brain; 2014 Mar; 137(Pt 3):693-706. PubMed ID: 24480483
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
